Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Efficacy of different nucleoside analog rescue therapies for entecavir-resistant chronic hepatitis B patients

Fig. 2

Virologic, biochemical, and serologic responses of different rescue therapy. Virologic response, biochemical response and serologic response in three groups were analyzed, A Rate of negative HBV DNA and rate of ALT normalization in different rescue therapy groups. B Mean HBV DNA level decline at 12, 24, 48 weeks in different rescue therapy groups. C Residual HBV DNA and HBV DNA change from baseline level in different rescue therapy groups. D Percentage of virologic response in different rescue therapy groups

Back to article page